基于PDGF通过RhoA/ROCK/HIF1α信号通路研究参竹心康方抗心肌纤维化作用机制OA
Mechanism of Shenzhu Xinkang Formula(参竹心康方)in anti-myocardial fibrosis via PDGF-mediated RhoA/ROCK/HIF1α signaling pathway
目的 探讨参竹心康方是否可以调控血小板衍生生长因子(PDGF)介导的Ras同源基因家族成员A(RhoA)/Rho相关卷曲螺旋激酶(ROCK)/缺氧诱导因子1α(HIF1α)信号通路改善异丙肾上腺素(ISO)诱导的大鼠心肌纤维化(MF).方法 通过背部皮下注射ISO诱导大鼠MF模型.将MF模型大鼠随机分为模型(Model)组,马来酸依那普利(Enalapril)组,参竹心康方(SZXK)组.另取未造模大鼠为空白(Control)组.分别给药4周.通过HE染色观察心肌组织病理变化;Masson染色评估心肌组织胶原纤维沉积面积;ELISA法检测心肌组织中Ⅰ型胶原蛋白(Collagen Ⅰ)、Ⅲ型胶原蛋白(Collagen Ⅲ)水平;qRT-PCR法检测心肌组织中PDGFRα mRNA的表达量;Western blot法检测心肌组织中α平滑肌肌动蛋白(α-SMA),RhoA,ROCK1,ROCK2,HIF1α的蛋白水平变化.结果 1)HE和Masson染色结果:与Control组比较,Model组的心肌细胞水肿,体积显著变大,排列杂乱无章,心肌间质中胶原沉积明显增加.与Model组比较,Enalapril组与SZXK组大鼠的心脏病理形态得到明显改善.2)ELISA法检测结果:与Control组比较,Model组大鼠心肌组织Collagen Ⅰ、Collagen Ⅲ水平显著升高(P<0.05).与Model组比较,Enalapril组与SZXK组大鼠心肌组织Collagen Ⅰ、Collagen Ⅲ水平显著降低(P<0.05).3)qRT-PCR法检测结果:与Control组比较,Model组PDGFRα mRNA表达明显升高(P<0.05).与Model组比较,Enalapril组与SZXK组PDGFRα mRNA表达明显降低(P<0.05).4)Western blot法检测结果:与Control组 比 较,Model组中α-SMA,RhoA,ROCK1,ROCK2,HIF1α的蛋白表达明显升高(P<0.05).与Model组比较,Enalapril组,α-SMA,ROCK1,ROCK2,HIF1α的蛋白表达明显降低(P<0.05),但RhoA的蛋白表达降低无显著差异(P>0.05);SZXK组的α-SMA,RhoA,ROCK1,ROCK2,HIF1α的蛋白表达明显降低(P<0.05).结论 参竹心康方可以通过调控PDGF介导RhoA/ROCK/HIF1α信号通路,发挥抗MF的作用.
Objective To investigate whether Shenzhu Xinkang Formula(参竹心康方,SZXKF)can ameliorate isoproterenol(ISO)-induced myocardial fibrosis(MF)in rats by regulating the platelet-derived growth factor(PDGF)-mediated Ras homolog gene family member A(RhoA)/Rho-associated coiled-coil kinase(ROCK)/hypoxia-inducible factor 1α(HIF1α)signaling pathway.Methods An MF rat model was established by subcutaneous injection of ISO.The MF model rats were randomly divided into the Control group,Model group,Enalapril maleate(Enalapril)group,and SZXKF(SZXK)group,with treatments administered for 4 weeks.Hematoxylin-eosin(HE)staining was used to observe histopathological changes in myocardial tissue.Masson's trichrome staining was performed to evaluate collagen fiber deposition in myocardial tissue.Enzyme-linked immunosorbent assay(ELISA)was used to measure the levels of Collagen I and Collagen III in myocardial tissue.Quantitative real-time reverse transcription polymerase chain reaction(qRT-PCR)was employed to detect the mRNA expression of PDGFRα in myocardial tissue.Western blot(WB)was conducted to assess the protein levels of α-smooth muscle actin(α-SMA),RhoA,ROCK1,ROCK2,and HIF1αin myocardial tissue.Results 1)Pathological staining results(HE and Masson):Compared to the Control group,myocardial cells in the Model group exhibited edema,significant enlargement in volume,and disordered arrangement,with markedly increased collagen deposition in the myocardial intersti-tial space.In contrast,both the Enalapril and SZXK groups showed significant improvement in cardiac pathological morphology com-pared to the Model group.2)ELISA results:Collagen I and Collagen III levels in myocardial tissue were significantly elevated in the Model group versus the Control group(P<0.05).Compared to the Model group,both the Enalapril and SZXK groups demonstrated sig-nificant reductions in Collagen I and Collagen III levels(P<0.05).3)qRT-PCR results:PDGFRαmRNA expression was significantly upregulated in the Model group compared to the Control group(P<0.05).In contrast,PDGFRαmRNA expression was markedly down-regulated in both the Enalapril and SZXK groups compared to the Model group(P<0.05).4)WB analysis:Protein expression levels of α-SMA,RhoA,ROCK1,ROCK2,and HIF1α were significantly increased in the Model group versus the Control group(P<0.05).Compared to the Model group,the Enalapril group showed significant reductions in RhoA,ROCK1,ROCK2,and HIF1α protein expression(P<0.05),but no significant difference in α-SMA expression(P>0.05).The SZXK group exhibited significant decreases in α-SMA,RhoA,ROCK1,ROCK2,and HIF1α protein levels(P<0.05).Conclusion SZXKF exerts anti-MF effects by downregulating PDGF to inhibit the RhoA/ROCK/HIF1α signaling pathway,thereby reducing excessive collagen fiber deposition in myocardial tissue of fibrotic rats.
朱辰瑶;赵启;赵文博;喻正科;颜旭;陈志红;庄红;汤济源;王凯丽;李媛彬;朱筱婧
常州市金坛区中医医院,江苏 常州 213200湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006常州市金坛区中医医院,江苏 常州 213200湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006湖南中医药高等专科学校,湖南 株洲 412012湖南省中西医结合医院,湖南省中医药研究院附属医院,湖南 长沙 410006
医药卫生
参竹心康方心肌纤维化PDGFRhoA/ROCK/HIF1α通路
Shenzhu Xinkang Formula(参竹心康方)Myocardial fibrosisPDGFRhoA/ROCK/HIF1α pathway
《时珍国医国药》 2026 (18)
3418-3425,8
国家自然科学基金青年基金(82200333)湖南省卫生健康委重点课题(C202319018666)湖南省自然科学基金(2025JJ80806)
评论